Forefront Analytics, LLC
Sector Allocation
- Other75.5%$69.5M
- Financials13.7%$12.6M
- Healthcare5.4%$5.0M
- Technology4.3%$3.9M
- Industrials0.8%$743,196
- Consumer Staples0.3%$264,600
AUM History
13fpro.ai/research/fund/forefront-analytics-llc-1696802
Conviction and streaks
Diversifying · top 10 = 82.7%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q2 2026
- VANGUARD$10.8M
- ISHARES$10.7M
MUFG
$10.5M- ISHARES$9.4M
- ISHARES$8.4M
- NUSHARES$7.0M
- DBX$6.9M
- FLEXSHARES$5.1M
NVDA
$3.9M- VANGUARD$3.4M
- ISHARES$3.3M
- ISHARES$2.6M
JPM
$1.6MDE
$743KUNH
$586KINCY
$577KEW
$557K- PROSHARES$551K
- PROSHARES$538K
ABT
$514K
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/forefront-analytics-llc-1696802
Forefront Analytics, LLC 13F holdings — Q2 2026
$92.0M portfolio (-16.3% QoQ) · 37 holdings · Q2 2026 13F · top 10 are 83% of the stock portfolio
- 1
VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF
$10.8M
11.7% of stocks
+0.1%This quarter—Since filed—HeldAIQuality—Est. buy— - 2
ISHARES TR - ESG AW MSCI EAFE
$10.7M
11.7% of stocks
-59%This quarter—Since filed—HeldAIQuality—Est. buy— $10.5M
11.4% of stocks
-48%This quarter-8.7%Since filed4+ qtrsHeld- 4
ISHARES TR - CORE HIGH DV ETF
$9.4M
10.2% of stocks
+403%This quarter—Since filed—HeldAIQuality—Est. buy— - 5
ISHARES TR - MSCI USA MMENTM
$8.4M
9.1% of stocks
+0.8%This quarter—Since filed—HeldAIQuality—Est. buy— - 6
NUSHARES ETF TR - NUVEEN ESG LRGVL
$7.0M
7.7% of stocks
-28%This quarter—Since filed—HeldAIQuality—Est. buy— - 7
DBX ETF TR - XTRACK MSCI EAFE
$6.9M
7.5% of stocks
-0.1%This quarter—Since filed—HeldAIQuality—Est. buy— - 8
FLEXSHARES TR - STOX GBL ESG SLT
$5.1M
5.5% of stocks
-51%This quarter—Since filed—HeldAIQuality—Est. buy— $3.9M
4.3% of stocks
+37%This quarter-4.1%Since filed4+ qtrsHeld- 10
VANGUARD TAX-MANAGED FDS - VAN FTSE DEV MKT
$3.4M
3.7% of stocks
+0.5%This quarter—Since filed—HeldAIQuality—Est. buy—
| # | Company | Value | Weight | This quarter | Since filed | Held | AI quality | Est. buy | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | VANGUARD INTL EQUITY INDEX F - FTSE EMR MKT ETF | $10.8M | 11.7% | +0.1% | — | — | — | — | |
| 2 | ISHARES TR - ESG AW MSCI EAFE | $10.7M | 11.7% | -59% | — | — | — | — | |
| 3 | $10.5M | 11.4% | -48% | -8.7% | 4+ qtrs | — | Estimated buy price is Pro: unlock with a free trial | ||
| 4 | ISHARES TR - CORE HIGH DV ETF | $9.4M | 10.2% | +403% | — | — | — | — | |
| 5 | ISHARES TR - MSCI USA MMENTM | $8.4M | 9.1% | +0.8% | — | — | — | — | |
| 6 | NUSHARES ETF TR - NUVEEN ESG LRGVL | $7.0M | 7.7% | -28% | — | — | — | — | |
| 7 | DBX ETF TR - XTRACK MSCI EAFE | $6.9M | 7.5% | -0.1% | — | — | — | — | |
| 8 | FLEXSHARES TR - STOX GBL ESG SLT | $5.1M | 5.5% | -51% | — | — | — | — | |
| 9 | $3.9M | 4.3% | +37% | -4.1% | 4+ qtrsAdded 2 qtrs in a row | 86.0#3 | Estimated buy price is Pro: unlock with a free trial | ||
| 10 | VANGUARD TAX-MANAGED FDS - VAN FTSE DEV MKT | $3.4M | 3.7% | +0.5% | — | — | — | — |
All holdings — Forefront Analytics, LLC (Q2 2026)
37 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | — | ISHARES TR - CORE S&P500 ETFetf/fund | — | $3.3M | 3.6% | 4,450 | -0.5% | — | — | 13F |
| 12 | — | ISHARES INC - CUR HD MSCI EMetf/fund | — | $2.6M | 2.8% | 58K | -0.6% | — | — | 13F |
| 13 | JPMORGAN CHASE & CO | Financials | $1.6M | 1.8% | 4,997 | +0.3% | 4+ qtrs | 71.8 | 13F | |
| 14 | DEERE & CO | Industrials | $743K | 0.8% | 1,172 | +3% | 4+ qtrs | 55.8 | 13F | |
| 15 | UNITEDHEALTH GROUP INC | Healthcare | $586K | 0.6% | 1,409 | -29% | 4+ qtrs | 62.6 | 13F | |
| 16 | INCYTE CORP | Healthcare | $577K | 0.6% | 5,091 | +20% | 4+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | Edwards Lifesciences Corp | Healthcare | $557K | 0.6% | 6,158 | -6% | 4+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | — | PROSHARES TR - PSHS ULT S&P 500etf/fund | — | $551K | 0.6% | 8,180 | +0.2% | — | — | 13F |
| 19 | — | PROSHARES TR - PSHS ULTRUSS2000etf/fund | — | $538K | 0.6% | 7,997 | +0.1% | — | — | 13F |
| 20 | ABBOTT LABORATORIES | Healthcare | $514K | 0.6% | 5,665 | +12% | 4+ qtrsAdded 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | WisdomTree, Inc. | Financials | $476K | 0.5% | 7,020 | -15% | 4+ qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | PFIZER INC | Healthcare | $438K | 0.5% | 18K | +39% | 4+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | Medtronic plc | Healthcare | $416K | 0.5% | 5,319 | — | 4+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | DANAHER CORP /DE/ | Healthcare | $389K | 0.4% | 2,040 | +58% | 4+ qtrsAdded 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | THERMO FISHER SCIENTIFIC INC. | Healthcare | $336K | 0.4% | 669 | +16% | 3 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $OTF | Blue Owl Technology Finance Corp. | Other | $307K | 0.3% | 30K | — | |||
| 27 | $LEGN | Legend Biotech Corp | Healthcare | $305K | 0.3% | 11K | -33% | |||
| 28 | $PM | Philip Morris International Inc. | Consumer Staples | $265K | 0.3% | 1,463 | +0.9% | |||
| 29 | $REGN | REGENERON PHARMACEUTICALS, INC. | Healthcare | $259K | 0.3% | 415 | -10% | |||
| 30 | — | SCHWAB STRATEGIC TR - US DIVIDEND EQ | — | $243K | 0.3% | 7,676 | -49% | |||
| 31 | — | VANGUARD INDEX FDS - VALUE ETF | — | $236K | 0.3% | 1,084 | -18% | |||
| 32 | $ZURA | Zura Bio Ltd | Healthcare | $159K | 0.2% | 27K | +81% | |||
| 33 | $GERN | GERON CORP | Healthcare | $114K | 0.1% | 89K | +61% | |||
| 34 | $CTMX | CytomX Therapeutics, Inc. | Healthcare | $94K | 0.1% | 25K | +101% | |||
| 35 | $BCYC | BICYCLE THERAPEUTICS PLC | Healthcare | $93K | 0.1% | 22K | +52% | |||
| 36 | $NKTX | Nkarta, Inc. | Healthcare | $82K | 0.1% | 29K | -34% | |||
| 37 | $ANNX | Annexon, Inc. | Healthcare | $81K | 0.1% | 14K | — |
What changed in Q2 2026
Against the previous quarter's 13F: 0 new, 19 added to, 15 trimmed, 2 sold out. Share-count changes; largest moves by dollar size first.
New positions (0)
No new positions this quarter.
Added to (19)
- ISHARES TR - CORE HIGH DV ETF+403%
now $9.4M
now $3.9M · held 4+ qtrs, 2 adds in a row
$DHRDANAHER CORP /DE/+58%
now $389K · held 4+ qtrs, 2 adds in a row
$PFEPFIZER INC+39%
now $438K · held 4+ qtrs
now $577K · held 4+ qtrs
$ZURAZura Bio Ltd+81%
now $159K · held 4+ qtrs
+13 more in the Excel export
Trimmed (15)
- ISHARES TR - ESG AW MSCI EAFE-59%
now $10.7M
now $10.5M · held 4+ qtrs
- FLEXSHARES TR - STOX GBL ESG SLT-51%
now $5.1M
- NUSHARES ETF TR - NUVEEN ESG LRGVL-28%
now $7.0M
now $586K · held 4+ qtrs
- SCHWAB STRATEGIC TR - US DIVIDEND EQ-49%
now $243K
+9 more in the Excel export
Sold out (2)
- DIMENSIONAL ETF TRUSTwas $222K
$MREOMereo BioPharma Group plcwas $42K
held 9+ qtrs
Holdings by quarter
Every 13F Forefront Analytics, LLC has filed, 34 earlier quarters. Pick one to see what it held then.
Is it too late to follow Forefront Analytics?
Q2 2026 13F filed with the SEC on Aug 13, 2026. Prices are closing prices as of Oct 26, 2026.
Average quality of Forefront Analytics's top 20 holdings: 72/100 (our AI quality score, weighted by position size; 17 of the 20 are scored)
Top 10 since filing
-6.1%
Value-weighted move of the 10 largest stock positions
Turnover
9%
Last quarter
Top 10 weight
83%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
95%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q3 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
Forefront Analytics, LLC disclosed 37 positions worth $92.0M in its Form 13F-HR for Q2 2026. During the quarter the fund opened 0 new positions and exited 2. The portfolio is most concentrated in Other (75.5% of disclosed assets). All figures are sourced directly from Forefront Analytics, LLC’s Form 13F-HR filing with the SEC under CIK 1696802.
Funds like this
managers whose biggest positions overlap Forefront Analytics'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: Forefront Analytics, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Forefront Analytics, LLC (SEC CIK: 1696802), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Forefront Analytics, LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.